title: Cyclosporin in psoriasis: how?
authors.forename: S R
authors.initials: SR
authors.lastname: Feldman
authors.forename: R
authors.initials: R
authors.lastname: Garton
mesh_terms: D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine